Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) Short Interest Update

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) was the recipient of a large decrease in short interest in April. As of April 30th, there was short interest totaling 6 shares, a decrease of 87.8% from the April 15th total of 49 shares. Based on an average daily volume of 289 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the stock are sold short.

Ambu A/S Price Performance

AMBBY opened at $9.78 on Thursday. The stock has a 50-day moving average price of $10.64 and a 200-day moving average price of $12.56. Ambu A/S has a 12-month low of $9.70 and a 12-month high of $16.78. The company has a current ratio of 2.86, a quick ratio of 1.67 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $2.30 billion, a P/E ratio of 34.91 and a beta of 1.06.

Ambu A/S (OTCMKTS:AMBBY) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a return on equity of 8.13% and a net margin of 7.81%.The firm had revenue of $246.39 million during the quarter.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.